Homburger advised funds managed by Apollo Capital Management L.P. on its investment in vVARDIS Holding AG
Homburger advised funds managed by Apollo Capital Management L.P. (Apollo Funds) on their strategic minority investment into vVARDIS Holding AG, a high-growth Swiss dental medtech company focused on non-invasive treatment solutions. The investment from Apollo Funds will support vVARDIS’ continued international expansion and the further development and commercialization of its product portfolio, building on prior …
𝐎𝐬𝐛𝐨𝐫𝐧𝐞 𝐂𝐥𝐚𝐫𝐤𝐞 𝐚𝐝𝐯𝐢𝐬𝐞𝐬 𝐥𝐞𝐚𝐝 𝐢𝐧𝐯𝐞𝐬𝐭𝐨𝐫 𝐌𝐲𝐨𝐬𝐨𝐭𝐢𝐬 𝐈𝐧𝐯𝐞𝐬𝐭𝐦𝐞𝐧𝐭𝐬 𝐁𝐕 𝐨𝐧 𝐭𝐡𝐞 €13 𝐦𝐢𝐥𝐥𝐢𝐨𝐧 𝐒𝐞𝐫𝐢𝐞𝐬 𝐀 𝐟𝐢𝐧𝐚𝐧𝐜𝐢𝐧𝐠 𝐨𝐟 𝐏𝐚𝐦𝐃𝐱
Osborne Clarke – Netherlands has advised Myosotis Investments BV as lead investor on the €13 million Series A financing of PamDx, an innovative Dutch CRO specialising in biomarker research and in‑vitro diagnostic services. The round, which also included investment from the EIC – European Innovation Council Fund and existing shareholder, marks an important milestone in …
Osborne Clarke – Netherlands assists 90NORTH with the sale of Rvados to Reliance backed by Böschen IT Group B.V.
Rvados is an established name in the Dutch IT landscape, supporting organisations with reliable and scalable managed services. Reliance, with the support of Böschen IT Group B.V., is strengthening its position through Rvados as a leading managed services provider.
Homburger advised 908 Devices Inc. on its acquisition of NIRLAB
On May 4, 2026, 908 Devices Inc. (NASDAQ: MASS) announced the completion of its acquisition of Swiss-based NIRLAB SA for a combination of cash and stock, including earn-out consideration. The NIRLAB Group develops near-infrared (NIR) spectroscopy solutions for instant material identification. 908 Devices is revolutionizing chemical analysis with its simple handheld devices for vital health, …
Continue reading “Homburger advised 908 Devices Inc. on its acquisition of NIRLAB”
Gibraltar Funds: The Case for Gibraltar
For too long, Gibraltar has been the fund domicile that sophisticated managers discover by accident. That is beginning to change. For summary Q&A click here.
E+H advised Yflavour on early-stage financing round
E+H advised Yflavour FlexCo, an innovative Graz-based startup specializing in the development of sustainable flavor solutions for plant-based meat alternatives, on the completion of a six-figure early-stage financing round. The investment was provided by the notable Austrian investors Angels United GmbH. The startup intends to use the funds to continue its growth trajectory.
GSK Stockmann advises Erhard & Stern on sale of Salutem medical centre in Mannheim
GSK Stockmann advised E&S Real Estate GmbH (Erhard & Stern), based in Heidelberg, on the sale of the “Salutem Praxisklinik” medical centre in Mannheim. The buyer is Swiss Life Asset Managers Deutschland GmbH, based in Cologne.
BBH Strengthens Its Leadership Team with Leading Competition Law Expert from A&O Shearman, Ivana Halamová Dobíšková
BBH, a leading Czech-Slovak law firm with international reach, is strengthening its management team with a new partner, Ivana Halamová Dobíšková, a leading expert in competition, regulatory, and EU law, who joins BBH from A&O Shearman. Her arrival represents a significant strategic reinforcement, particularly in one of the firm’s key priorities – competition law. The …
Kudun and Partners Strengthens Capital Markets Leadership and Expands Regional Capability with Strategic Senior Hires
BANGKOK, 7 May 2026 – Kudun and Partners (KAP) has significantly strengthened its domestic and regional capabilities with the integration of Manunya & Associates Limited, led by Manunya Thitinuntawan, bringing over 10 years of the firm’s established practice together with her 25 years of professional experience, and onboarding of Krissen Pillay as Counsel in the …
Argus Partners Advises Spinny on Multiple Fundraises, including its ~USD 170 million Series F round and ~USD 170 million Series G round
Argus Partners is pleased to announce that it has advised Valuedrive Technologies Private Limited (“Spinny”) across multiple fundraises, including its Series F fundraise of approximately USD 170 million and its Series G fundraise of approximately USD 170 million.